Skip to main content

Fluidigm Medium-Cell HT IFC

Fluidigm has launched its medium cell, high-throughput integrated fluidic circuit to isolate single cells for mRNA sequencing analysis. The circuit captures up to 800 medium-size cells with higher single-cell capture efficiency, which enables researchers to scale cell lineage studies using Fluidigm's C1 system, the company said. The new workflow supports the identification of cell subpopulations present at low abundance across a wide range of cell types, including cancer and stem cells.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.